Perioperative management of transcatheter, aortic and mitral, double valve-in-valve implantation during pregnancy through left ventricular apical approach

Catheter-Based Interventions for the Management of Valvular Heart Disease During Pregnancy

“…It is therefore essential to understand the potential advantages and limitations of this technology when performed during pregnancy. There are currently 7 reported cases of TAVR during pregnancy ( Table 2 ), 53 , 54 , 55 , 56 , 57 , 58 , 59 1 in a native bicuspid AV (BAV) and 6 in deteriorated bioprosthetic valves. The only case of TAVR in a native valve was reported by Hodson et al 53 in a 22-year-old female with the BAV, presenting at 15 weeks’ gestation with dizziness and dyspnea on exertion.…”

“…In women with degenerative bioprosthetic valves presenting as symptomatic severe MS in pregnancy, there are case reports of transcatheter MV implantation ( Table 4 ). 57 , 103 , 104 All cases presented between 20 and 22 gestational weeks with symptomatic severe MS secondary to the deteriorated bioprosthetic valve. One of these patients had an additional severely stenotic aortic bioprosthetic valve, who underwent successful concomitant, transcatheter double balloon-expandable VIV implantations through the left ventricular apical route with significant reduction of both transmittal and transaortic pressures ( Table 4 ).…”